M/s. JDS Co., Ltd. Pharmaceutical Import Profile — Myanmar (DGFT 2022–2026)

Name: M/s. JDS Co., Ltd. Pharmaceutical Import Records from India — 2 Products, $353.3K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

M/s. JDS Co., Ltd. — Pharmaceutical Importer Profile (2026) | 2 Products, $353.3K Trade | TransData Nexus

M/s. JDS Co., Ltd.

Pharmaceutical Importer · Myanmar · Advanced Antibiotics Focus · $353.3K Total Trade · DGFT Verified

M/s. JDS Co., Ltd. is a pharmaceutical importer based in Myanmar with a total trade value of $353.3K across 2 products in 2 therapeutic categories. Based on 13 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. M/s. JDS Co., Ltd. sources from 1 verified Indian supplier, with Sun Pharmaceutical Industries Limited accounting for 100.0% of imports.

M/s. JDS Co., Ltd. — Import Portfolio & Supplier Network

M/s. JDS Co., Ltd. import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to M/s. JDS Co., Ltd.?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Sun Pharmaceutical Industries Limited	$3.3M	120	100.0%

M/s. JDS Co., Ltd. sources from 1 verified Indian supplier across 92 distinct formulations. The sourcing is highly concentrated — Sun Pharmaceutical Industries Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

Formulation	Value	Ships
Bacqure injection 500MG Pack : 1 vial batch : dfg1535d Each vial contains imipenem ph, eur/USP (sterile) equivalent	$100.0K	2
Aspime injection 1g Pack: 1 vial batch:5029001 Each vial contains: cefepime hydrochloride u.s.p. eq. to cefepime	$100.0K	2
Oframax injection 1 GM Pack: 1 vial batch: 5007024, 5007023 Each vial conts. sterile ceftriaxone sodium USP eq. to	$100.0K	2
Caverta tablets 100MG Pack : 4s strip batch : dff1835a, dff1836a, dff1834a eachtab conts sildnafil citrate eq to 100MG	$90.1K	3
Ursocol TAB 300MG 5x10b mymr Pack : box5x10s batch : pte3643a	$68.6K	3
Oframax injection 1 GM. Pack : 1 vial batch : 3007039, 3007038 Each vial contains sterile ceftriaxone sodium USP	$62.8K	3
Sporidex syrup 125MG Pack: 60ML bottle	$62.5K	2
Caverta tablets 100MG Pack: 4s strip	$50.0K	1
Dazolic tabs (ornidazole tablets 500MG)	$50.0K	1
Aspime injection 1g Pack: 1 vial	$50.0K	1
Bacqure injection 500MG Pack:1 vial	$50.0K	1
Chericof throat lozenges-orange	$50.0K	1
Dazolic tabs(ornidazole tablets 500MG	$50.0K	1
Aspime injection 1g Pack:1 vial	$50.0K	1
Caverta tablets 100MG Pack:stp 4t/c	$50.0K	1

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Ornidazole	Advanced Antibiotics	$200.0K	4	1.1%	7
2	Volini	Brand Names & OTC Products	$153.3K	9	5.2%	5

M/s. JDS Co., Ltd. imports 2 pharmaceutical products across 2 categories into Myanmar totaling $353.3K.

M/s. JDS Co., Ltd. — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

M/s. JDS Co., Ltd. is a prominent pharmaceutical importer and distributor based in Myanmar, specializing in the importation, distribution, and sale of a diverse range of pharmaceutical and personal care products. Established in 2003, JDS operates as a dedicated healthcare business unit under the Capital Diamond Star Group (CDSG), one of Myanmar's largest conglomerates with interests spanning FMCG, retail, healthcare, and more. (cdsg.com.mm)

Headquartered in Yangon, JDS has expanded its operations to include 10 branches and 19 dealers across Myanmar, achieving over 95% distribution coverage nationwide. The company imports, distributes, and sells more than 700 different pharmaceutical and personal care products to hospitals, general practitioners, retail outlets, pharmacies, wholesalers, modern trade, and government institutions. Notably, some of the brands imported and distributed by JDS have become household names in Myanmar. (cdsg.com.mm)

2Distribution Network

JDS Co., Ltd. boasts an extensive distribution network with 10 branches and 19 dealers strategically located across Myanmar, ensuring comprehensive coverage of the country's pharmaceutical market. The company operates state-of-the-art ISO-certified warehouses in Yangon and other regional areas, adhering to international standards for storage and distribution. These facilities include cold chain capabilities, maintaining temperatures between 2-8°C, which are essential for the storage of temperature-sensitive pharmaceutical products. (cdsg.com.mm)

JDS's logistics operations are designed to meet international standards, facilitating efficient and timely delivery of products. The company offers rapid delivery services, including in-town deliveries within 24 hours and urgent deliveries to hospitals and clinics within 5 hours, achieving a delivery accuracy rate of 97% over orders. (cdsg.com.mm)

3Industry Role

In Myanmar's pharmaceutical supply chain, M/s. JDS Co., Ltd. functions primarily as a pharmaceutical importer and distributor. The company imports finished pharmaceutical formulations from international suppliers, particularly from India, and distributes these products to various stakeholders, including hospitals, general practitioners, retail outlets, pharmacies, wholesalers, modern trade, and government institutions. JDS's extensive distribution network and comprehensive service offerings position it as a key player in ensuring the availability of pharmaceutical products across Myanmar. (cdsg.com.mm)

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — M/s. JDS Co., Ltd.

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

JDS Co., Ltd. demonstrates a high level of sourcing concentration, with a total import value of $353,000 USD from India across 13 shipments, importing 92 unique formulations. The company's top two imported products are Ornidazole ($200,000, Rank #7, 1.1% share) and Volini ($153,000, Rank #5, 5.2% share), accounting for 100% of the total import value. (en.nbd.ltd)

This sourcing strategy indicates a strategic choice to maintain a focused product portfolio, potentially leveraging strong relationships with Indian suppliers. However, such concentration may expose JDS to risks associated with supply chain disruptions, currency fluctuations, and regulatory changes in the source country. The absence of alternative suppliers in the import data suggests a need for diversification to mitigate potential risks.

2Supply Chain Resilience

The resilience of JDS Co., Ltd.'s Indian supply chain appears limited due to the company's reliance on a single supplier, SUN Pharmaceutical Industries Limited, which accounts for 100% of the total import value. This single-source dependency poses risks related to supply chain disruptions, regulatory changes, and geopolitical factors affecting India. The lack of backup suppliers and limited formulation diversity further exacerbate these vulnerabilities.

To enhance supply chain resilience, JDS may consider diversifying its supplier base and incorporating a broader range of formulations. Additionally, evaluating alternative shipping routes and ensuring compliance with international quality standards can contribute to a more robust supply chain.

Importing Pharmaceuticals into Myanmar — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Myanmar

1Regulatory Authority & Framework

In Myanmar, the Food and Drug Administration (FDA) under the Ministry of Health serves as the primary regulatory authority overseeing pharmaceutical imports. The National Drug Law, enacted in 1992, governs the registration, licensing, quality assurance, labeling, and advertising of pharmaceutical products. Under this law, all pharmaceutical raw materials and drugs must be registered with the FDA before importation, and entities involved in manufacturing, importing, exporting, storing, distributing, or selling these products must obtain the necessary licenses. (servicetrade.gov.mm)

2Import Licensing & GMP

Import licensing requirements in Myanmar stipulate that pharmaceutical products must be registered with the FDA prior to importation. Applicants must submit a dossier in the ASEAN Common Technical Dossier (ACTD) format, covering administrative, quality, non-clinical, and clinical data. For imported products, mandatory documents include the Certificate of Pharmaceutical Product (CPP), Good Manufacturing Practice (GMP) certificate, and a Letter of Authorization (LOA) from the manufacturer.

3Quality & Labeling

M/s. JDS Co., Ltd. — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

JDS Co., Ltd.'s focus on importing advanced antibiotics and brand-name over-the-counter (OTC) products aligns with the growing demand for effective treatments and consumer healthcare solutions in Myanmar. The company's top two imported products, Ornidazole and Volini, reflect this strategic emphasis. The market demand for these products is driven by the increasing prevalence of infections and the need for accessible pain relief options among the Myanmar population.

2Sourcing Profile

JDS Co., Ltd. primarily sources generic drugs from India, favoring formulations that are well-established and widely used in the Myanmar market. India's robust pharmaceutical manufacturing sector, characterized by compliance with international quality standards and competitive pricing, makes it a preferred sourcing destination for JDS.

3Market Positioning

Based on its product mix, JDS Co., Ltd. serves multiple segments of the Myanmar pharmaceutical market, including retail pharmacies, hospitals, government tenders, and wholesale distribution. The company's extensive distribution network and diverse product portfolio enable it to cater to a broad spectrum of healthcare needs across the country.

Seller's Guide — How to Become a Supplier to M/s. JDS Co., Ltd.

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to enter the Myanmar market by partnering with JDS Co., Ltd. To capitalize on this opportunity, Indian exporters should focus on meeting JDS's quality standards, ensuring compliance with Myanmar's regulatory requirements, and offering competitive pricing. Diversifying the product range and providing value-added services can further enhance the attractiveness of the partnership.

2Requirements & Qualifications

Indian exporters seeking to supply M/s. JDS Co., Ltd. and the Myanmar market must obtain the necessary import licenses and registrations from the FDA Myanmar. This includes submitting a dossier in the ASEAN Common Technical Dossier (ACTD) format, providing a Certificate of Pharmaceutical Product (CPP), Good Manufacturing Practice (GMP) certificate, and a Letter of Authorization (LOA) from the manufacturer.

3How to Approach

To establish a partnership with JDS Co., Ltd., Indian exporters should initiate contact through the company's official communication channels, such as email at [email protected] or phone at +95-9260950001. Engaging in discussions about product offerings, quality standards, and compliance with Myanmar's regulatory requirements is essential. Participating in tenders and understanding the regulatory filing process will facilitate a smoother entry into the Myanmar market. Setting realistic timelines and maintaining open communication will be crucial for a successful partnership.

Frequently Asked Questions — M/s. JDS Co., Ltd.

What products does M/s. JDS Co., Ltd. import from India?

M/s. JDS Co., Ltd. imports 2 pharmaceutical products across 2 categories. Top imports: Ornidazole ($200.0K), Volini ($153.3K).

Who supplies pharmaceuticals to M/s. JDS Co., Ltd. from India?

M/s. JDS Co., Ltd. sources from 1 verified Indian suppliers. The primary supplier is Sun Pharmaceutical Industries Limited (100.0% of imports, $3.3M).

What is M/s. JDS Co., Ltd.'s total pharmaceutical import value?

M/s. JDS Co., Ltd.'s total pharmaceutical import value from India is $353.3K, based on 13 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does M/s. JDS Co., Ltd. focus on?

M/s. JDS Co., Ltd. imports across 2 categories. The largest: Advanced Antibiotics (56.6%), Brand Names & OTC Products (43.4%).

Get Full M/s. JDS Co., Ltd. Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.